We are live on ! Find out more
PKBO

Peak Bio, Inc. Common Stock
PKBO

Delisted

PKBO was delisted on the 9th of January, 2023.

Back to rankings

43 hedge funds and large institutions have $43.3M invested in Peak Bio, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

2% more funds holding

Funds holding: 42 → 43 (+1)

1% less capital invested

Capital invested by funds: $43.7M → $43.3M (-$382K)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
43
Holders Change
+1
Holders Change %
+2.38%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$580K
2
MTCM
Mint Tower Capital Management
Netherlands
+$558K
3
MSU
Mizuho Securities USA
New York
+$496K
4
WRBC
W.R. Berkley Corp
Connecticut
+$300K
5
CSS
Cubist Systematic Strategies
Connecticut
+$254K

Top Sellers

Rank Fund Capital Flow
1
MC
Meteora Capital
Florida
-$1.98M
2
SFM
Spartan Fund Management
Canada
-$599K
3
KIM
Karpus Investment Management
New York
-$496K
4
Citadel Advisors
Citadel Advisors
Florida
-$314K
5
BCM
Basso Capital Management
Connecticut
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
DFCM
26
Dark Forest Capital Management
Puerto Rico
$492K – – –
CH
27
CVI Holdings
Delaware
$472K +$8.94K +900 +2%
CM
28
Crestline Management
Texas
$457K – – –
PMAM
29
Picton Mahoney Asset Management
Ontario, Canada
$400K – – –
LCM
30
Landscape Capital Management
New Jersey
$377K +$3.06K +308 +0.8%
AA
31
AQR Arbitrage
Connecticut
$350K – – –
CCM
32
CAAS Capital Management
New York
$251K – – –
Walleye Capital
33
Walleye Capital
New York
$212K – – –
RCM
34
Rivernorth Capital Management
Florida
$200K – – –
HF
35
HRT Financial
New York
$199K +$1.41K +142 +0.7%
Goldman Sachs
36
Goldman Sachs
New York
$194K -$79.4K -8,000 -29%
CF
37
Cantor Fitzgerald
New York
$160K – – –
Walleye Trading
38
Walleye Trading
New York
$160K – – –
SMC
39
Smith, Moore & Co
Missouri
$149K +$148K +14,880 New
Millennium Management
40
Millennium Management
New York
$125K -$25.5K -2,564 -17%
Ohio Public Employees Retirement System (OPERS)
41
Ohio Public Employees Retirement System (OPERS)
Ohio
$30K – – –
UBS Group
42
UBS Group
Switzerland
$24K – – –
TRCT
43
Tower Research Capital (TRC)
New York
$1K – – –
MC
44
Meteora Capital
Florida
– -$1.98M -200,835 Closed
SFM
45
Spartan Fund Management
Canada
– -$599K -60,692 Closed
OMC
46
Old Mission Capital
Illinois
– -$184K -18,659 Closed
1
2

PKBO Hedge Fund Activity: Q3 2022 in Review

43 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Common Stock (PKBO) for Q3 2022, worth a combined $43.3M — down 0.87% from $43.7M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PKBO positions and 3 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $580K. The largest seller was Meteora Capital, exiting entirely with an estimated $1.98M sold.

  • 43 institutional investors held Peak Bio, Inc. Common Stock (PKBO) as of Q3 2022, up from 42 in Q2 2022.
  • Funds reported $43.3M of Peak Bio, Inc. Common Stock stock for Q3 2022, down 0.87% quarter-over-quarter.
  • 4 funds opened new Peak Bio, Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of +1 holder.
  • The largest Peak Bio, Inc. Common Stock buyer in Q3 2022 was Janus Henderson Group, an estimated $580K added.
  • The largest Peak Bio, Inc. Common Stock seller in Q3 2022 was Meteora Capital, an estimated $1.98M sold.

Based on aggregated 13F filings for Q3 2022.